Status:
TERMINATED
Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Staphylococcal Aureus Infection
Recurrent Staphylococcal Infection
Eligibility:
All Genders
2+ years
Brief Summary
The incidence of community-associated (CA) staphylococcal infections, especially those caused by methicillin-resistant Staphylococcus aureus (MRSA), has increased dramatically in recent years. Althoug...
Detailed Description
The incidence of community-associated (CA) staphylococcal infections, especially those caused by methicillin-resistant Staphylococcus aureus (MRSA), has increased dramatically in recent years. Althoug...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age greater than or equal to 2 years.
- Current or past S. aureus infection, either invasive or soft tissue.
- Willingness to allow storage of blood and tissue samples for future use.
- Subjects will be eligible without regard to race, gender, or ethnic origin.
- EXCLUSION CRITERIA:
- Infection with known HIV-1, HIV-2 as demonstrated by ELISA and Western blot or viral load testing.
- Evidence of intravenous drug abuse in the year prior to the first (or only) S. aureus infection.
- Previously known immunodeficiency syndrome.
- Evidence of active malignancy.
- Any condition that the investigators judge would compromise the results of the study.
- Diabetes mellitus.
- Evidence of healthcare-associated infection invasive device, history of surgery with implantation of artificial device in previous 12 months, history of surgery without device implantation in previous 12 month, or dialysis, hospitalization, or residence in long-term care facility in previous 12 months. An exception to these exclusion criteria is hospitalization for the acute S. aureus infection at the time of enrollment.
Exclusion
Key Trial Info
Start Date :
May 28 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 17 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00911430
Start Date
May 28 2009
End Date
September 17 2014
Last Update
December 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892